Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.01M Buy
32,500
+27,100
+502% +$2.91M ﹤0.01% 5041
2026
Q1
$553K Buy
+5,400
New +$550K ﹤0.01% 9396
2025
Q4
Sell
-6,400
Closed -$553K 13195
2025
Q3
$553K Sell
6,400
-90,500
-93% -$7.16M ﹤0.01% 8718
2025
Q2
$7.39M Buy
96,900
+44,300
+84% +$3.24M ﹤0.01% 3290
2025
Q1
$3.73M Sell
52,600
-48,600
-48% -$3.8M ﹤0.01% 4221
2024
Q4
$7.92M Sell
101,200
-130,000
-56% -$12.1M ﹤0.01% 2948
2024
Q3
$23.7M Buy
231,200
+167,900
+265% +$13.9M ﹤0.01% 1652
2024
Q2
$4.8M Buy
63,300
+10,100
+19% +$718K ﹤0.01% 3506
2024
Q1
$3.99M Buy
53,200
+19,200
+56% +$1.53M ﹤0.01% 4015
2023
Q4
$2.5M Buy
34,000
+15,600
+85% +$965K ﹤0.01% 4908
2023
Q3
$846K Buy
+18,400
New +$817K ﹤0.01% 7013

Other funds holding NUVL

Jeff Yass's NUVL Position: Q2 2026 in Review

Jeff Yass increased its Nuvalent (NUVL) stake by 210% in Q2 2026, buying an estimated $6.25M and bringing the position to 85,717 shares worth $10.6M. The position accounts for ﹤0.01% of the portfolio, ranked #3316.

Jeff Yass first reported a position in NUVL in Q1 2022 and has held it in 15 quarters since. 288 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

  • Jeff Yass held 85,717 shares of Nuvalent worth $10.6M as of Q2 2026.
  • Jeff Yass bought 58,064 Nuvalent shares in Q2 2026, an estimated $6.25M.
  • Nuvalent made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #3316 holding.
  • Jeff Yass first reported a position in Nuvalent in Q1 2022 and has held it in 15 quarters since.
  • 288 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.